In the BioHarmony Drug Report Database

"Preview" Icon

Carbinoxamine

Clistin, Karbinal Er (carbinoxamine) is a small molecule pharmaceutical. Carbinoxamine was first approved as Clistin on 1982-01-01. It is used to treat allergic conjunctivitis, allergic rhinitis perennial, angioedema, and vasomotor rhinitis in the USA. Carbinoxamine maleate’s patent is valid until 2029-03-29 (FDA).

 

Trade Name

 

Clistin, Karbinal Er
 

Common Name

 

carbinoxamine
 

ChEMBL ID

 

CHEMBL864
 

Indication

 

allergic conjunctivitis, allergic rhinitis perennial, angioedema, vasomotor rhinitis
 

Drug Class

 

Image (chem structure or protein)

Carbinoxamine structure rendering